Cardiac Toxicity: Clinical Trials

37 trials for Cardiac Toxicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

18 completed, 9 unknown, 5 recruiting, 4 terminated. 8 Not applicable, 7 Phase 3, 4 Phase 2, 2 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable8Completed 4, Unknown 3, Terminated 1
Phase 37Completed 5, Terminated 1, Unknown 1
Phase 24Completed 2, Recruiting 1, Terminated 1
Phase 12Completed 1, Unknown 1
Phase 42Recruiting 2

Follow Cardiac Toxicity: new trials by email Literature Review of Cardiac Toxicity trials Research Report on Cardiac Toxicity

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies
ECHOCARDIOGRAPHY, ELECTROCARDIOGRAPHY (ECG), LABORATORY TESTS - Cardiac Toxicity, Cancer
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS3002025-02-282025-03-04
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Sacubitril-valsartan, Placebo - Breast Cancer, Neoplasm, Breast
Phase 4RecruitingSilesian Centre for Heart Diseases6002024-04-172025-03-14
The STOP-MED CTRCD Trial
Stopping Heart Failure Medication(s) - Heart Failure, Cardiotoxicity
Phase 4RecruitingDinesh Thavendiranathan3352024-03-042026-07-07
Translating ECHOS2 Into an mHealth Platform
Computerized Intervention Authoring Software (CIAS) - Childhood Cancer, Cardiac Toxicity
Not applicableCompletedWashington University School of Medicine732023-07-052024-01-11
Cardiovascular Effects of Intrathecal Hyperbaric Prilocaine or Bupivacaine in Surgery Under Spinal Anesthesia
Hyperbaric bupivacaïne, Hyperbaric prilocaïne - Spinal Anesthesia, Cardiac Toxicity
Not applicableUnknownCentre Hospitalier Universitaire Saint Pierre602023-03-222023-03-24
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
Lipitor 40mg Tablet - Cardiac Toxicity, Early-stage Breast Cancer
Phase 2RecruitingRutgers, The State University of New Jersey602022-09-192025-11-14
Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude
High altitude - HER2-positive Breast Cancer, Targeted Therapy
UnknownAffiliated Hospital of Qinghai University1322021-10-012021-10-01
Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment.
Impedance cardiography - Non-small Cell Lung Cancer, Cardiac Toxicity
Active not recruitingSun Yat-sen University2312021-06-052026-03-11
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer Radiotherapy
Echocardiography - Non-small Cell Lung Cancer, Radiation Toxicity
UnknownMilitary Institute od Medicine National Research Institute1002021-05-012021-07-23
Risk Assessment Model of Trastuzumab-related Cardiotoxicity in Breast Cancer Patients
Trastuzumab - Cardiac Toxicity, Antitumor Drugs
UnknownPeking University Third Hospital2402021-01-082021-07-15
Exercise Response After Revalidation in Cancer Patients
Cardiorespiratory exercise test - Oncology, Cardiac Toxicity
Not applicableUnknownUniversitair Ziekenhuis Brussel1912020-08-012020-07-08
Effects of Anti-VEGF Targeted Drugs on Patients' Blood Pressure and Endothelial Function
Anti-VEGF - Cardiac Toxicity, VEGF
UnknownPeking University Third Hospital302019-07-052021-07-15
Association Between Telomere Length and Cardiac Dysfunction
Relative telomere length - Cardiac Toxicity, Acute Leukemia
CompletedAir Force Military Medical University, China3002019-01-012020-06-01
The CAROLE (CArdiac Related Oncologic Late Effects) Study
Coronary Artery Disease, Cardiac Disease
CompletedNorthwell Health2012017-06-272019-05-21
BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study
Subclinical cardiac lesions and biomarkers - Breast Cancer, Cardiac Toxicity
Not applicableCompletedSophie JACOB1182015-10-012023-11-08
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
Chemoradiotherapy - Cardiac Toxicity, Lung Cancer Stage III
RecruitingOdense University Hospital1002015-08-012023-12-06
Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers
Moxifloxacin - Cardiac Toxicity
Phase 1UnknownHaiyan Li802014-04-012014-04-21
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Magnetic resonance imaging, Physical Activity, Healthy Living - Cardiac Toxicity, Malignant Neoplasm
Not applicableCompletedWake Forest University Health Sciences282013-01-012023-05-19
Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment (PREDICT)
Laboratory Biomarker Analysis, Questionnaires - Cardiac Toxicity, Unspecified Adult Solid Tumor, Protocol Specific
Not applicableUnknownM.D. Anderson Cancer Center5972011-01-252019-05-21
Early Detection of Anthracycline Cardiotoxicity by Echocardiographic Analysis of Myocardial Deformation in 2D Strain
Echographic analysis of myocardial deformation in 2D strain - Leukemia, Cardiac Toxicity
Not applicableCompletedUniversity Hospital, Bordeaux1002010-09-282026-05-28

Showing 20 of 37. Sign in to see all of them.

Narrower conditions

Cardiotoxicity (37)  ·  Breast Neoplasms (13)  ·  Neoplasms (7)  ·  Lymphoma (5)  ·  Breast Neoplasms, Male (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Heart Diseases (2)  ·  Heart Failure (2)  ·  Inflammatory Breast Neoplasms (2)  ·  Leukemia (2)  ·  Lung Neoplasms (2)  ·  Radiation Injuries (2)  ·  Sarcoma (2)  ·  Altitude Sickness (1)  ·  Breast Diseases (1)

Broader conditions

Cardiovascular Diseases (37)  ·  Chemically-Induced Disorders (37)  ·  Drug-Related Side Effects and Adverse Reactions (37)  ·  Pathologic Processes (37)  ·  Pathological Conditions, Signs and Symptoms (37)  ·  Wounds and Injuries (37)  ·  Heart Diseases (35)  ·  Radiation Injuries (35)  ·  Neoplasms (21)  ·  Neoplasms by Site (16)  ·  Skin Diseases (13)  ·  Skin and Connective Tissue Diseases (13)  ·  Breast Diseases (12)  ·  Neoplasms by Histologic Type (9)  ·  Hemic and Lymphatic Diseases (6)

Interventions

Doxorubicin (9)  ·  Dexrazoxane (7)  ·  Razoxane (6)  ·  Cyclophosphamide (5)  ·  Trastuzumab (5)  ·  Filgrastim (4)  ·  Echocardiography (3)  ·  Etoposide (3)  ·  Granulocyte Colony-Stimulating Factor (3)  ·  Methotrexate (3)  ·  Radiotherapy (3)  ·  Vincristine (3)  ·  Bleomycin (2)  ·  Chemotherapy, Adjuvant (2)  ·  Cisplatin (2)

Sponsors

Children's Oncology Group (5)  ·  National Cancer Institute (NCI) (3)  ·  Peking University Third Hospital (2)  ·  Wake Forest University Health Sciences (2)  ·  AHS Cancer Control Alberta (1)  ·  Affiliated Hospital of Qinghai University (1)  ·  Air Force Military Medical University, China (1)  ·  Cambridge University Hospitals NHS Foundation Trust (1)  ·  Cancer Trials Ireland (1)  ·  Centre Hospitalier Universitaire Saint Pierre (1)  ·  Dinesh Thavendiranathan (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Haiyan Li (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)

Countries

United States (20)  ·  Canada (6)  ·  China (6)  ·  Australia (3)  ·  Poland (3)  ·  Switzerland (3)  ·  Belgium (2)  ·  France (2)  ·  United Kingdom (2)  ·  Denmark (1)  ·  Ireland (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Spain (1)

Top investigators

Cindy Schwartz, MD (2)  ·  Antonella Lombardo (1)  ·  Atul Pathak, MD PhD (1)  ·  Barbara L. Asselin, MD (1)  ·  Bassam Abdulkarim, MD (1)  ·  Bernard Cosyns, Professor (1)  ·  Cameron K. Tebbi, MD (1)  ·  Carrie G Lenneman, MD, MSCI (1)  ·  Daniel Lenihan, MD (1)  ·  Donald W. Northfeld, MD (1)  ·  Douglas B Sawyer, MD, PhD (1)  ·  Edith A. Perez, MD (1)  ·  Erika Waters, PhD, MPH (1)  ·  Gretchen Wells, MD, PhD (1)  ·  Haiyan Li, MD (1)

Results publications

PMID 19584400, PMID 22689804, PMID 22911615, PMID 23273589, PMID 25114718, PMID 25975632, PMID 27056179, PMID 28123764, PMID 28459938, PMID 28525534, PMID 30732640, PMID 31171092, PMID 31727075, PMID 32154021, PMID 32819449, PMID 37449716, PMID 37504555, PMID 38634292, PMID 38845066, PMID 39187877, PMID 39810280, PMID 41877348

NIH funding

P30CA012197 (1), P30CA015083 (1), P30CA036727 (1), P30CA068485 (1), R01CA167821 (1), R21CA226960 (1), U01CA097452 (1), U10CA030969 (1), U10CA031946 (1), U10CA032102 (1), U10CA081920 (1)